AbbVie pangenotypic combination cures almost all hard-to-treat people with HCV genotype 3
US Veterans Affairs and Australia show potential for rapid elimination of hepatitis C
Tenofovir alafenamide approved for hepatitis B, works well with less effect on bones
Self-sampling for HIV testing popular with gay men who have not recently tested, but less uptake by African people
Long term decline in consistent condom use among Australian gay men
Grazoprevir/elbasvir + sofosbuvir highly effective for hard-to-treat genotype 3 hepatitis C patients
